1-对甲苯-1H-咪唑 | 25372-10-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1-对甲苯-1H-咪唑
• 英文名称: 1-p-tolyl-1H-imidazole
• 英文别名: 1-(4-methylphenyl)-1H-imidazole；1-(4-tolyl)-1H-imidazole；1-(4-methylphenyl)-1H-imidazol；N-(4-tolyl)imidazole；N-4-methylphenyl imidazole；1-(p-tolyl)-1H-imidazole；1-(4-methylphenyl)imidazole
• CAS: 25372-10-5
• 化学式: C₁₀H₁₀N₂
• mdl: MFCD01795837
• 分子量: 158.203
• InChiKey: IEAYECHBGTTWPZ-UHFFFAOYSA-N

物化性质

• 熔点：
  45-47 °C
• 沸点：
  287.9±19.0 °C(Predicted)
• 密度：
  1.04±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933290090

反应信息

• 作为反应物：
  描述：

  1-对甲苯-1H-咪唑 在 氟硼酸钠 、 potassium tert-butylate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 51.0h， 生成 tris(2-(3-(p-tolyl)-2,3-dihydro-1H-imidazol-1-yl)ethyl)amine
  参考文献：
  名称：

  Unexpected reactivity resulting from modifications of the ligand periphery: Synthesis, structure, and spectroscopic properties of iron complexes of new tripodal N-heterocyclic carbene (NHC) ligands

  摘要：

  The chelating ligand tris-[2-(3-aryl-imidazol-2-ylidene) ethyl] amine (TIMENR, R = aryl = 2,6-xylyl (xyl), mesityl (mes)) has provided access to reactive transition metal complexes. Here, two new tripodal N-heterocyclic carbene ligands of the TIMENR system (R = aryl = tolyl (tol), 3,5-xylyl (3,5xyl)), featuring sterically less demanding aryl substituents were synthesized. With these ligands, Fe(II) precursor complexes could be obtained, namely [(TIMENtol)Fe](BF4)(2) (3) and [(TIMEN3,5xyl)Fe(CH3CN)](PF6)(2) (7), which showed unexpected reactivity upon reduction. Treatment of the compounds with sodium amalgam yield the tris-and bis-metallated products, [(TIMENtol***)Fe] (4) and [(TIMEN3,5xyl**)Fe] (8), respectively. While the Fe(III) complex 4 is relatively inert towards oxygen, the Fe(II) complex 8 is prone to oxidation. This oxidation of 8 can readily be observed in chlorinated solvents, producing the Fe(III) complex [(TIMEN3,5xyl**)Fe](PF6) (9). All new ligand imidazolium precursors and metal complexes were characterized by single crystal X-ray structure determination. (C) 2010 Elsevier B. V. All rights reserved.

  DOI：

  10.1016/j.ica.2010.07.039
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 硝酸 作用下， 生成 1-对甲苯-1H-咪唑
  参考文献：
  名称：

  Marckwald, Chemische Berichte, 1892, vol. 25, p. 2362

  摘要：

  DOI：

文献信息

• INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS
  申请人：ECKHARDT Matthias

  公开号：US20140163025A1

  公开（公告）日：2014-06-12

  The present invention relates to compounds of general formula I, wherein the groups (Het)Ar and R 1 are defined as in claim 1 , which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

  本发明涉及一般式I的化合物， 其中基团(Het)Ar和R1如权利要求1所定义， 具有有价值的药理特性，特别是结合GPR40受体并调节其活性。这些化合物适用于治疗和预防可以受到该受体影响的疾病，如代谢性疾病，特别是2型糖尿病。
• Highly active bidentate N-heterocyclic carbene/ruthenium complexes performing dehydrogenative coupling of alcohols and hydroxides in open air
  作者：Zhi-Qin Wang、Xiao-Sheng Tang、Zhao-Qi Yang、Bao-Yi Yu、Hua-Jing Wang、Wei Sang、Ye Yuan、Cheng Chen、Francis Verpoort

  DOI：10.1039/c9cc03519b

  日期：——

  Eight bidentate NHC/Ru complexes, namely [Ru]-1–[Ru]-8, were designed and prepared. In particular, [Ru]-2 displayed extraordinary performance even in open air for the dehydrogenative coupling of alcohols and hydroxides. Notably, an unprecedentedly low catalyst loading of 250 ppm and the highest TON of 32 800 and TOF of 3200 until now were obtained.

  设计并制备了八种双齿NHC / Ru络合物，即[Ru] -1– [Ru] -8。尤其是，Ru-2在醇和氢氧化物的脱氢偶联中甚至在露天中也表现出非凡的性能。值得注意的是，迄今为止获得了前所未有的低催化剂负载量250 ppm和最高TON 32800和TOF 3200。
• [EN] COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS<br/>[FR] AGENTS PHARMACEUTIQUES EN COMBINAISON EN TANT QU'INHIBITEURS DE RSV
  申请人：ENANTA PHARM INC

  公开号：WO2019067864A1

  公开（公告）日：2019-04-04

  The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

  本发明涉及用于治疗呼吸道合胞病毒（RSV）感染的药物剂，该药物剂可以单独或连续给予受试者，治疗包括给予一种有效抑制RSV功能的化合物以及具有抗RSV活性的另一种化合物或化合物组合。
• SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160326125A1

  公开（公告）日：2016-11-10

  The present invention provides compounds of Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used medicaments.

  本发明提供了规范中定义的Formula (I)的化合物以及包含任何此类新化合物的组合物。这些化合物是内皮酶抑制剂，可用作药物。
• Air-stable palladium(0) phosphine sulfide catalysts for Ullmann-type C–N and C–O coupling reactions
  作者：Arpi Majumder、Ragini Gupta、Mrinmay Mandal、Madhu Babu、Debashis Chakraborty

  DOI：10.1016/j.jorganchem.2014.11.018

  日期：2015.4

  N-arylation and O-arylation of aryl halides by Ullmann-type cross coupling reaction under mild reaction conditions in a short reaction time. Two phosphine sulphide ligands and their corresponding Pd(0) complexes namely [Pd(p2S2)(dba)] and [Pd(pp3S4)(dba)], were synthesized, where p2S2 is 1,2-bis(diphenylphosphino)ethane disulfide, pp3S4 is tris[2-(diphenylphosphino)ethyl]phosphine tetrasulfide and dba

  本文描述了在温和的反应条件下，在较短的反应时间内，钯（0）催化Ullmann型交叉偶联反应进行芳基卤化物的N-芳基化和O-芳基化的有效方法。合成了两个硫化膦配体及其相应的Pd（0）络合物，即[Pd（p 2 S 2）（dba）]和[Pd（pp 3 S 4）（dba）]，其中p 2 S 2为1， 2-双（二苯基膦基）乙烷二硫化物，pp 3 S 4是三[2-（二苯基膦基）乙基]膦四硫化物，dba是二亚苄基丙酮。通过改变温度，溶剂，碱和催化剂的负载量，确定了使用碘代苯和苯并咪唑进行芳基化反应的最佳反应条件。使用碘代苯/溴苯和具有不同空间和电子性质的各种取代的芳基胺/苯酚/醇进行交叉偶联反应，从而以良好或优异的收率得到所需的N-芳基胺/二芳基醚/烷基芳基醚（ 70–94％）。